The Future of Atrial Fibrillation Care Starts Here

Our device delivers precise, low-dose therapy and painless cardioversion to transform cardiac care.

We are a late-stage medical device company dedicated to improving patient quality of life through innovative, minimally invasive, and cost-efficient solutions that address unmet healthcare needs.

Learn More About Our Mission

Postoperative atrial fibrillation (POAF) is a common complication after cardiac surgery, affecting up to 60% of patients, particularly in aging populations. POAF is a serious condition that must be treated to prevent severe outcomes like stroke, heart failure, and death.

Learn More About AFIB

What is AFIB?

The "Big Little Problem"

Postoperative atrial fibrillation (POAF) is a major complication after cardiac surgery, causing longer hospital stays and increased patient costs. While treatments like IV antiarrhythmic drugs and external cardioversion restore normal heart rhythm, they come with serious side effects, including drug toxicity, burns, and pain.

Learn More About The Solution

Featured

Native Cardio's Newsroom

Native Cardio Team Publishes Endocarditis - Diagnosis and Treatment

Analysis estimates high prevalence of undiagnosed atrial fibrillation in the U.S

Peerbridge Health and Native Cardio Team Up to Improve Outcomes for Cardiac Surgery Patients

2 3 4

Learn how patients living with postoperative atrial fibrillation (POAF) and their caregivers navigate its challenges and explore treatment options.

"The hardest part was not knowing what comes next. Finding answers and support made all the difference."